medigraphic.com

2012, Number 2

Rev Mex Med Fis Rehab 2012; 24 (2)

Effectiveness of magnetic stimulation in patients with overactive bladder

Moreno VR, Arreortua CS, Cruz RMM

Language: Spanish
References: 35
Page: 31-37
PDF size: 148.96 Kb.


ABSTRACT

Introduction: Overactive bladder is a syndrome characterized by increased urinary frequency, urinary urgency accompanied with or without incontinence. The recommendation as first-line treatment is the use of antimuscarinic agents; however, the number of side effects is poorly tolerated. Material and methods: We applied the quality of life questionnaire, visual analogue scale, voiding diary and urodynamic study was performed. By sealed envelope was randomly selected treatment: group A: Tolterodine and group B: Magnetic stimulation. At the end of treatment, were retested with urodynamic study. Results: We recruited 29 patients, eliminated during the mapping and monitoring 14 patients by default, allergic reactions to medications and pregnancy, leaving 15 patients for analysis. Significant differences were found in the quality of live questionnaire items of role limitation, physical limitation, social limitation and personal relationships. There were significant differences in reducing emergency periods in favor of group B. Conclusion: Magnetic stimulation is a treatment option for patients with overactive bladder due to good performance, comfort, absence of side effects and good choice for patients taking multiple drugs.


REFERENCES

  1. Bernard TH. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. International Urogynecology Journal 2010; 21: 5-26.

  2. Misom I. How widespread are the symptoms of on overactive bladder and how are they managed? A population based prevalence study. British Journal of Urology International 2001; 87: 760-66.

  3. Stewart WF. Prevalence and burden of overactive bladder in the United States. World Journal of Urology 2003; 20: 327-336.

  4. Dávila H. Primer Consenso Venezolano de Vejiga Hiperactiva. Caracas, 2005.

  5. James SD. Pathophysiology of detrusor overactivity. Journal of Pelvic Medicine and Surgery 2004; 10(2): 43-51.

  6. William DS. Pathophysiology of overactive bladder and urge urinary incontinence. Reviews in Urology 2002; 4(Suppl 4): S7-S18.

  7. Alan JW. Overactive bladder: a better understanding of pathophysiology: diagnosis and management. The Journal of Urology 2006; 175: S5-S10.

  8. González-Hidalgo M. Exploración neurofisiológica del suelo de la pelvis. Revista de Neurología 1998; 26(151): 432-438.

  9. Dallosso HM. The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women. British Journal of Urology International 2003; 92: 69-77.

  10. Espuña PM. Síntomas del tracto urinario inferior en la mujer y la afección de la calidad de vida. Resultados de la aplicación del King’s Health Questionnaire. Actas Urológicas Españolas 2006; 30(7): 684-691.

  11. Abrams P. Drug treatment of overactive bladder. Efficacy, cost and quality-of-life considerations. Drugs 2004; 64(15): 1643-1656.

  12. Debra EI. The economic impact of overactive bladder syndrome in six western countries. British Journal of Urology International 2008; 103: 202-209.

  13. Adam JF. Urodynamic classification of patients with symptoms of overactive bladder. The Journal of Urology 2003; 169: 529-534.

  14. Urinary incontinence: the management of urinary incontinence in women, 2003. Clinical Guidelines of National Institute for Health and Clinical Excellence. Disponible en: http://guidance.nice.org.uk/CG40 (Acceso en septiembre 2010).

  15. Abrams P. International consultation on incontinence. Cap. 7, 2nd Edition, Paris 2002; “Urodynamics”.

  16. Tomonari Y. Neuromodulation for the treatment of urinary incontinence. International Journal of Urology 2008; 15: 665-672.

  17. Chapple CR. The contemporary pharmacological management of overactive bladder. An International Journal of Obstetrics and Gynecology 2006; 113(2): 19-28.

  18. Carretero MC. Vejiga hiperactiva: Tratamiento con un nuevo antimuscarínico. Avances Farmacológicos 2006; 25(1): 88-90.

  19. Fujishiro. Magnetic stimulation on the sacral roots for the treatment of stress incontinence: an investigational study and placebo controlled trial. The Journal of Urology 2000; 164(4): 1277-9.

  20. Fujishiro. Magnetic stimulation of the sacral roots for the treatment of urinary frequency and urge incontinence: an investigational study and placebo controlled trial. The Journal of Urology 2002; 168(3): 1036-1039.

  21. Roger PG. Electromagnetic pelvic floor stimulation: applications for the gynecologist. Obstetrical and Gynecological Survey 2000; 55(11): 715-720.

  22. Satoru T, Tadaichi K. Overactive bladder: magnetic versus electrical stimulation. Current Opinion in Obstetrics and Gynecology 2003; 15: 429-433.

  23. Pearllyn Q. A critical review on magnetic stimulation: what is its role in the management of pelvic floor disorder? Current Opinion in Urology 2005; 15: 231-235.

  24. H. Overactive bladder: an update. Current Opinion in Urology 2007; 17: 231-236.

  25. O’ Reilly BA. A prospective randomized double-blind controlled trial evaluating the effect on trans-sacral magnetic stimulation in women with overactive bladder. International Urogynecology Journal 2008; 19: 497–502.

  26. Liao KK. Effect of sacral-root stimulation on the motor cortex in patients with idiopathic overactive bladder syndrome. Neurophysiologie Clinique/Clinical Neurophysiology 2008; 38: 39-43.

  27. Muñoz-Duyos A. Incontinencia fecal: neurofisiología y neuromodulación. Cirugía Española 2004; 76(2): 65-70.

  28. Jin HC. Symptom change in women with overactive bladder after extracorporeal magnetic stimulation: a prospective trial. International Urogynecology Journal 2007; 18: 875-880.

  29. Bradshaw HD. The acute effect of magnetic stimulation of the pelvic floor on involuntary detrusor activity during natural filling and overactive bladder symptoms. British Journal of Urology International 2003; 91: 810-813.

  30. Almeida. Urodynamic and clinical evaluation of 91 female patients with urinary incontinence treated with perineal magnetic stimulation: 1-year follow-up. The Journal of Urology 2004; 171(4): 1571-1575.

  31. Shobeiri. A pilot study of extracorporeal magnetic stimulation of the pelvic floor for the treatment of women with fecal incontinence and underactive pelvic floor muscles. Journal of Pelvic Medicine and Surgery 2007; 13(1): 19-26.

  32. BUT. Functional Magnetic stimulation for mixed urinary incontinence. The Journal of Urology 2005; 173(5): 1644-1646.

  33. Petra JV. Effects of magnetic stimulation in the treatment of pelvic floor dysfunction. British Journal of Urology International 2006; 97: 1035-1038.

  34. Galloway NT. Extracorporeal magnetic innervations therapy for stress urinary incontinence. Urology 1999; 53: 1108-11.

  35. Wein AJ. Diagnosis and treatment of the overactive bladder. Urology 2003; 62(Suppl 2): 20-27.




2020     |     www.medigraphic.com